Trial Comparing the Safety and Efficacy of Two Different Oral VPV Doses With Placebo as Treatment for RV in Participants With COPD
for Rhinovirus Infection
14 locations incl. Tempe
Sponsor: Altesa Biosciences, Inc.
Sex: All·Age: 40 - 85
Code: NCT07610395·Phase 2·Recruiting